Clinical Trial Update: Canadian Pegvisomant Compassionate Study In Acromegalic Patients [Phase 4]

View source ↗

Summary

Pfizer's pegvisomant compassionate-use Phase 4 study in acromegaly patients has completed in Canada.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Somavert (pegvisomant)

Snippet

Sponsor: Pfizer | Conditions: Acromegaly | Phase 4 | Status: COMPLETED